Boston, May 02, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research, the demand for Cell-Based Assays: Technologies and Global Markets is estimated to increase from $35.3 billion in 2024 to $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
This report covers the global market for cell-based assay technologies, analyzing its size, projected growth, and key segments such as instruments, consumables, services, and software. It explores applications such as drug discovery, toxicity testing, and research, with end users such as universities, pharma/biotech companies and research organizations. It also reviews regional markets (North America, Europe and Asia-Pacific) key companies, industry trends and partnerships.
Interesting facts:
- Reduced Animal Testing: Cell-based assays are becoming popular because they provide accurate human-like models, reducing the need for animal testing in drug research.
- Organoids Mimic Organs: New organoid technology creates miniature versions of organs, improving drug testing and disease research, and possibly reducing the need for human trials.
- AI-Powered Assays: Automation and AI are speeding up cell-based assays, helping researchers identify safe and effective drugs more quickly.
Factors contributing to the market’s growth include:
- Rising Incidence of Chronic Diseases.: An increasing number of people worldwide are being affected by long-term conditions like diabetes, heart disease, and cancer.
- Rising Demand for Drug Discovery and Development: The rising demand for drug discovery and development highlights the growing need for new, effective treatments to address various diseases and unmet medical needs.
- Demand for Personalized Medicine.: Demand for personalized medicine reflects the growing need for tailored treatments based on individual genetics, lifestyle, and biology to improve patient outcomes.
- Increasing Investment in Drug R&D.: Increasing investment in drug R&D signifies growing financial support for developing new therapies and innovations to combat diseases and improve healthcare.
Request a sample copy of the report on cell-based assays technologies and global markets
Report Synopsis
| Report … |